United Immunity

United Immunity, Co., Ltd. is engaged in the research, development, manufacturing, and sales of drugs focused on cancer immunotherapy, particularly for cold tumors. The company has developed the seed promoter program for combination immunotherapy using the anti-tumor T-cell activation technology "T-ignite."